Evidence map›Paper›PMID 38827268›Full record

ArticleJACC. Case reports2024

Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection.

Stefanos Zafeiropoulos, Nicholas J Beccarino, Stavros Stavrakis, Stavros Zanos, Raman Mitra

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefanos ZafeiropoulosInstitute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
Nicholas J BeccarinoNorthwell Health, North Shore University Hospital, Department of Cardiology, Division of Electrophysiology, Manhasset, New York, USA.
Stavros StavrakisHeart Rhythm Institute, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
Stavros ZanosInstitute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
Raman MitraNorthwell Health, North Shore University Hospital, Department of Cardiology, Division of Electrophysiology, Manhasset, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardioneuroablation is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. This study reports a case of drug-refractory VVS after COVID-19 infection, successfully managed with cardioneuroablation.

Indexed as

cardioinhibitorycardioneuroablationCOVID-19syncopevasovagal

Identifiers

PMID38827268
PMCPMC11137558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.